A phase 3 double-blind, randomized, vehicle-controlled study of desonide foam in pediatric and adolescent patients with mild to moderate atopic dermatitis

被引：0
|
作者：
Friedlander, SF
Loss, R
Schlessinger, J
Potts, A
机构：
[1] Childrens Hosp San Diego, San Diego, CA USA
[2] Dermatol Associates Rochester PA, Rochester, NY USA
[3] Skin Specialists PC, Omaha, NE USA
[4] Connet Corp, Palo Alto, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB85 / AB85
页数：1
相关论文
共 50 条
  • [1] Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: Results from a randomized, double-blind, vehicle-controlled study
    Schachner, LA
    Lamerson, C
    Sheehan, MP
    Boguniewicz, M
    Mosser, J
    Raimer, S
    Shull, T
    Jaracz, E
    [J]. PEDIATRICS, 2005, 116 (03) : E334 - E342
  • [2] Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial
    Saeki, Hidehisa
    Ito, Kensuke
    Yokota, Daisuke
    Tsubouchi, Hidetsugu
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (03) : 607 - 614
  • [3] Safety of desonide emulsion formulation foam in pediatric and adolescent subjects with mild to moderate atopic dermatitis
    Hogan, D
    Friedlander, SF
    Kempers, S
    Abraham, S
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB185 - AB185
  • [4] Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study
    Zirwas, Matthew
    Draelos, Zoe D.
    DuBois, Janet
    Kircik, Leon
    Moore, Angela
    Gold, Linda Stein
    Higham, Robert C.
    Navale, Lynn
    Burnett, Patrick
    Berk, David R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB47 - AB47
  • [5] Pimecrolimus cream 1% for the treatment of facial atopic dermatitis: Exploratory analysis of a double-blind, randomized, vehicle-controlled study in pediatric patients
    Korman, Neil
    Kianifard, Farid
    Parneix-Spike, Anne
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB107 - AB107
  • [6] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 854 - 862
  • [7] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB52 - AB52
  • [8] The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study
    Afshar, M.
    Kotol, P.
    Miller, J.
    Gallo, R.
    Hata, T.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) : 426 - 428
  • [9] Efficacy and safety results of a randomized, double-blind, vehicle-controlled phase 2 study of roflumilast foam 0.3% in patients with seborrheic dermatitis
    Zirwas, M.
    [J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 : 13 - 13
  • [10] Prednicarbate 0.25% ointment in the treatment of atopic dermatitis: A vehicle-controlled double-blind study
    Lawlor, F
    Black, AK
    Greaves, M
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 1995, 6 (04) : 233 - 235
12345